Press "esc" to clear
Go to Advanced Search

Showing results

110 of 205030
BuntingAtSunset.Mercyforweb.2017.jpg

Article ID: 702500

21 Mercy Physicians Named Among Region’s “Top Docs” in November 2018 Issue of Baltimore Magazine

Mercy Medical Center, Baltimore

A total of 21 Mercy Medical Center physicians were recognized in Baltimore Magazine’s November 2018 “Top Docs” issue, representing 19 separate specialties, ranging from breast cancer surgery to pediatrics to urogynecology.

Released:
22-Oct-2018 12:05 PM EDT
Open in New Tab
Comment

Article ID: 702579

Beverly K. Philip, M.D., FASA, elected first vice president of the American Society of Anesthesiologists

American Society of Anesthesiologists (ASA)

The American Society of Anesthesiologists (ASA) today announced Beverly K. Philip, M.D., FASA, has been named first vice president of the ASA. Dr. Philip was elected at the ANESTHESIOLOGY® 2018 annual meeting in San Francisco and will serve for one year.

Released:
22-Oct-2018 12:05 PM EDT
Open in New Tab

Article ID: 702574

Seattle Surgeon Ronald V. Maier, MD, FACS, Installed as New President of the American College of Surgeons

American College of Surgeons (ACS)

Ronald V. Maier, MD, FACS, the Jane and Donald D. Trunkey Endowed Chair in Trauma Surgery, vice-chairman, department of surgery, and professor of surgery, University of Washington School of Medicine, Seattle, was installed as the 99th President of the American College of Surgeons (ACS) during the Convocation ceremony that preceded the opening of the annual ACS Clinical Congress, which is one of the largest international surgical meetings in the world.

Released:
22-Oct-2018 12:00 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702537

High-dose, high-precision radiation therapy safe and effective for kidney cancer patients with only one kidney

American Society for Radiation Oncology (ASTRO)

Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have two, according to an analysis of the largest-ever, international dataset of solitary kidney patients to receive this emerging treatment. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
21-Oct-2018 11:05 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702536

Men with low- and intermediate-risk prostate cancer can safely benefit from fewer, higher-dose radiation treatments

American Society for Radiation Oncology (ASTRO)

Stereotactic body radiation therapy (SBRT) is a safe and effective treatment for men with low- and intermediate-risk prostate cancer, according to a long-term, multi-institutional study. The study clears the way for patients who may wish to shorten their course of treatment without fear of increasing their risk for severe, adverse side effects. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
21-Oct-2018 11:05 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702535

Radiation Therapy Outcomes Better for African-American Prostate Cancer Patients Than Caucasian Patients

American Society for Radiation Oncology (ASTRO)

While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new analysis of genetic data from a large prospective registry and clinical data from several randomized trials indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
21-Oct-2018 11:05 PM EDT
Open in New Tab
Comment
  • Embargo expired:
    22-Oct-2018 12:00 PM EDT

Article ID: 702534

Combined therapy including pelvic lymph node radiation provides significant benefit for prostate cancer patients

American Society for Radiation Oncology (ASTRO)

The first report of a large international clinical trial shows that, for men who show signs of prostate cancer after surgical removal of their prostates, extending radiation therapy to the pelvic lymph nodes combined with adding short-term hormone therapy to standard treatment can extend the amount of time before their cancer spreads. Findings will be presented in a news briefing today at noon ET from the American Society for Radiation Oncology (ASTRO) Annual Meeting.

Released:
22-Oct-2018 12:00 AM EDT
Open in New Tab
Comment

Article ID: 702552

Developing an Automated Virtual Health Coach

University of Illinois at Chicago

An interdisciplinary group of researchers at the University of Illinois at Chicago has received a grant from the National Science Foundation to create an SMS-based virtual health coach that would help overweight people set and achieve healthy eating and exercise goals. The $1.2 million, four-year grant will enable the development of an automated virtual health coaching system whose benefits would be accessible to a much larger population than those currently using human health coaches — whose services can be expensive — to help them achieve their exercise and weight-loss goals.

Released:
22-Oct-2018 11:05 AM EDT
Open in New Tab
Comment

Article ID: 702565

Antipsychotics Ineffective For Treating ICU Delirium

Vanderbilt University Medical Center

Critically ill patients are not benefitting from antipsychotic medications that have been used to treat delirium in intensive care units (ICUs) for more than four decades, according to a study released today in the New England Journal of Medicine.

Released:
22-Oct-2018 11:05 AM EDT
Open in New Tab
Comment

Article ID: 702566

New tool gives deeper understanding of glioblastoma

Cornell University

Researchers in the lab of Charles Danko at the Baker Institute for Animal Health have developed a new tool to study genetic “switches” active in glioblastoma tumors that drive growth of the cancer. In a new paper in Nature Genetics, they identified key switches in different types of tumors, including switches linked to how long a patient survives.

Released:
22-Oct-2018 11:05 AM EDT
Open in New Tab

Showing results

110 of 205030

Chat now!